News
Video
Author(s):
Alex Hacopian, MD, speaks about patient-reported outcomes from a presbyopia-correcting IOL at the 2025 ASCRS annual meeting.
The Eye Care Network reported to Los Angeles, California for the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting. While in LA, editors from Ophthalmology Times met with panelists, presenters and leaders from industry and the clinical research space to hear more about the programming at this year's event.
Alex Hacopian, MD, presented a paper on bilateral implantation of the TECNIS Odyssey IOL (Johnson & Johnson Vision). A total of 80 eyes of 40 subjects at one site were targeted, and subjects were assessed at least 3 months postoperatively at a single visit. In this video, Dr. Hacopian discusses patient selection and counseling for real-world cohorts of patients with presbyopia.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Companies announce presentations at upcoming 2025 ARVO Annual Meeting